As per the research report, the Asia Pacific Atherectomy Devices Market was worth USD 77 million in 2019 and estimated to be growing at a CAGR of 7.1%, to reach USD 109 million by 2024 during the forecast period 2019-2024. The market is showcasing evident potential in the mentioned forecasting period. The market continues to gain momentum with the rapid development in the medical industry.
Atherectomy is a minimally invasive surgical method for the plaque which blocks vein grafts or coronary arteries. The rise in the prevalence of peripheral artery ailments in the world, specifically in the geriatric population, has fuelled the demand for atherectomy methods in the forecast period. Since a lot of medical facilities are using atherectomy methods to treat the peripheral artery disease, it will propel the demand and sales of atherectomy devices in the coming few years.
Few of the key factors responsible for the growth of atherectomy devices market are the growing inclination towards minimally invasive surgeries. Minimally invasive surgical methods deliver quick procedural time, faster recovery, reduced risk of complications and infections. The Asia Pacific atherectomy devices market is also showing significant increase in demand owing to sudden rise in high risk old age population and prevalence of lifestyle-related ailments as well as peripheral artery diseases.
This research report segmented and sub-segmented into the following categories:
Within these, directional atherectomy devices segment presently dominates the Asia Pacific market owing to its early entry in the market. Variety of products and better capacity of plaque reduction also contributes to the development of this segment.
The Asia Pacific Atherectomy Devices Market is expected to exhibit the highest growth rate in the forecast period because of developing economy and increased spending on the healthcare.
The Top companies leading in the APAC Atherectomy Devices Market profiled in the report are Bayer HealthCare, C. R. Bard, Inc., Cardinal Health (Cordis), Avinger, Inc., Boston Scientific Corporation, Straub Medical AG, St. Jude Medical, Cardiovascular Systems, Inc., and Spectranetics.
1. Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Type
5.1.1 Introduction
5.1.2 Directional
5.1.3 Rotational
5.1.4 Orbital
5.1.5 Lateral
5.1.5 Y-o-Y Growth Analysis, By Type
5.1.6 Market Attractiveness Analysis, By Type
5.1.7 Market Share Analysis, By Type
5.2 Application
5.2.1 Introduction
5.2.2 Peripheral
5.2.3 Cardiovascular
5.2.4 Neurovascular
5.2.5 Y-o-Y Growth Analysis, By Application
5.2.6 Market Attractiveness Analysis, By Application
5.2.7 Market Share Analysis, By Application
5.3 End User
5.3.1 Introduction
5.3.2 Hospitals
5.3.3 Surgical Centers
5.3.4 Research Laboratories
5.3.5 Academic Institutes
5.3.6 Y-o-Y Growth Analysis, By End User
5.3.7 Market Attractiveness Analysis, By End User
5.3.8 Market Share Analysis, By End User
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Type
6.1.3.3 By Application
6.1.3.4 By End User
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Type
6.1.4.3 By Application
6.1.4.4 By End User
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Type
6.1.5.3 By Application
6.1.5.4 By End User
6.2 China
6.3 India
6.4 Japan
6.5 South Korea
6.6 Australia
7. Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 Bayer HealthCare
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 C. R. Bard, Inc.
8.3 Cardinal Health (Cordis)
8.4 Boston Scientific Corporation
8.5 Straub Medical AG
8.6 St. Jude Medical
8.7 Spectranetics
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10. Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
